Cannabinoids in the Treatment of Epilepsy: A Review
Cannabinoids have been studied for their role in the treatment of epilepsy for many years. The U.S. Food and Drug Administration (FDA) approved them for the treatment of some refractory syndromes in 2018. Cannabidiol and tetrahydrocannabinol are the most commonly studied cannabinoids and have been...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2021-10-01
|
| Series: | European Medical Journal |
| Online Access: | https://www.emjreviews.com/neurology/article/cannabinoids-in-the-treatment-of-epilepsy-a-review/ |